Basis for Biochemical Discordance Between Activated Partial Thromboplastin Time and Anti-factor Xa in Patients with Continuous Flow Left Ventricular Assist Device on Unfractionated Heparin Infusion

被引：0
|
作者：
Yarmohammadi, Hirad
Feng, Amy J.
Alraies, Chadi M.
Thenappan, Thenappan
Colvin, Monica
John, Ranjit
Eckman, Peter
Pritzker, Marc
Adatya, Sirtaz
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Ventricular assist devices; Thrombosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19105
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices
    Yarmohammadi, H.
    Holley, C.
    Thennapin, T.
    Duval, S.
    Pritzker, M.
    Cogswell, R.
    John, R.
    Colvin-Adams, M.
    Eckman, P.
    Adatya, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S23 - S24
  • [2] Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-Factor Xa measurements in continuous-flow left ventricular assist device patients
    Ton, Van-Khue
    Eisenberger, Andrew
    Jennings, Douglas
    Colombo, Paolo C.
    Topkara, Veli K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1365 - 1367
  • [3] Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial, thromboplastin time in patients supported with continuous-flow left ventricular assist devices
    Adatya, Sirtaz
    Sunny, Roy
    Fitzpatrick, Megan J.
    Colvin, Monica
    Thennapan, Thennapan
    John, Ranjit
    Zantek, Nicole Dodge
    Pritzker, Marc
    Eckman, Peter
    Uriel, Nir
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1311 - 1320
  • [4] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [5] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [6] Anti-Factor Xa and Activated Partial Thromboplastin Time Strategies for Heparin Dosing After HeartMate3 Left Ventricular Assist Device Implantation
    Feng, I.
    Kurlansky, P. A.
    Powley, T. R.
    Vinogradsky, A. V.
    Hynds, M. A.
    Yang, C. G.
    Hastie, J. M.
    Sutherland, L. D.
    Shih, H.
    Yuzefpolskaya, M.
    Colombo, P. C.
    Sayer, G. T.
    Naka, Y.
    Uriel, N.
    Takeda, K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S389 - S389
  • [7] Correlation Between, Anti-Factor Xa, Activated Partial. Thromboplastin Time, Activated Clotting Time, and R Time in Patients Supported With Continuous-Flow Left Ventricular Assist Devices
    Taimeh, Ziad
    Roy, Samit
    Fitzpatrick, Megan
    Pritzker, Marc
    Eckman, Peter
    John, Ranjit
    Colvin, Monica
    Thenappan, Thenappan
    Uriel, Nir
    Adatya, Sirtaz
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S116 - S116
  • [8] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
  • [9] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    [J]. THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
  • [10] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    [J]. PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
12345